INFARNOSYS

Novel biomarker diagnostic system for the assessment of the prognosis of acute myocardial ischemia/reperfusion injury and infarction and the effectiveness of the treatment... For both men and women, coronary artery disease is the leading cause of death in Europe in spite of the fact that 80% of premature heart diseases are preventable. Earlier and better diagnosis of cardiac ischemia and reperfusion injury is crucial for reducing the number of deaths connected to cardiovascular diseases. Measuring MMP and nitrotyrosine levels enables predicting the occurrence of heart attack and helps to start the treatment much earlier. Our diagnostic marker combination has already been tested in several pre-clinical studies and in a pilot clinical study (Bencsik et al, Eur J Clin Invest, 2015)... - automated zymography-based device for the detection of MMP-2 and MMP-9 activities as a Minimum Viable Product for research market entry

Primary location: Budapest European Union